WebLymphatica successfully renews its ISO 13485 certificate from TÜV SÜD After in depth audit, the notified body TÜV SÜD granted the renewal of the ISO 13485 certification to … WebLymphatica Medtech has raised a total of $433K in funding over 7 rounds. Their latest funding was raised on Nov 26, 2024 from a Debt Financing round. Lymphatica Medtech is funded by 4 investors. Foundation for Technological Innovation (FIT) and EASME - EU Executive Agency for SMEs are the most recent investors.
About Lymphedema - Lymphatica Medtech
WebIn addition, Lymphatica processes personal data concerning health in the context of clinical studies and post-market surveillance of patients using Lymphatica’s products. Lymphatica Medtech SA – EPFL Innovation Park, 1015 Lausanne is in this case the controller. This code of conduct applies to: Web13 apr. 2024 · Dezember 2024 aktualisiert von: Lymphatica Medtech SA. Klinische Pilotstudie zur Bewertung der Sicherheit und Durchführbarkeit eines neuen implantierbaren Geräts zur Behandlung von Arm-Lymphödemen. Bei der vorliegenden Studie handelt es sich um eine erste, einarmige, offene Einzelzentrumsstudie am Menschen zur … is beluga real
Valentina Triacca – Co-founder & COO – Lymphatica …
WebLymphedema is a chronic condition resulting in a local swelling, often of one arm or one leg, caused by the build- up of lymph under the skin. WebLymphatica Medtech; Swiss Vault; Mobile Health; Nala; GenomSys Scailyte Topadur Xatena; 👏👏👏 We thank you for your valuable contribution and are happy to see such exciting ideas vitalizing the Swiss healthcare ecosystem. Applications for the 2024 SHS Smarter Healthcare Booster Program will open in October 2024. Web8 mar. 2024 · Meet Lymphatica Medtech co-founder Marco Pisano and find out how he improves the lives of people with lymphatic diseases. Marco Pisano co-founded Lymphatica Medtech, a Venture Leader Medtech that develops medical devices to treat lymphedema—chronic swelling of arms and legs that of... one is the loneliest number that you\u0027ll ever